EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease

Xiuli Guo, Si Wen, Jiao Wang, Xiaobian Zeng, Hongyuan Yu, Ying Chen, Xinwang Zhu, Li Xu

Phytomedicine · 2024-07 · 130 · 155705

DOI: 10.1016/j.phymed.2024.155705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-07. Verfasst von Xiuli Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524003, PR China; Department of Laborat…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Quercetin, PPAR alpha, Dasatinib. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Senolytic combination of dasatinib and quercetin (DQ) is the most studied senolytics drugs used to treat various age-related diseases. However, its protective activity against diabetic kidney disease (DKD) and underlying mechanisms are uncertain. PURPOSE: To investigate the functions and potential mechanisms of the senolytics DQ on DKD. METHODS: Diabetic db/db mice were administrated DQ or transfected with over-expressed PPARα or shPPARα vector. The positive control group was administered irbesartan. Renal function and fibrotic changes in kidney tissue were tested. Single-cell RNA-seq (scRNA-seq) was conducted to analyze the differential transcriptome between the diabetic and control mice. Molecular docking simulation was used to assess the combination of DQ and potential factors. Moreover, tubular epithelial cells under high-glucose (HG) conditions were incubated with DQ and transfected with or without over-expressed PPARα/siPPARα vector. RESULTS: DQ significantly improved renal function, histopathological and fibrotic changes, alleviated lipid deposition, and increased ATP levels in mice with DKD. DQ reduced multiple fatty acid oxidation (FAO) pathway-related proteins and up-regulated PPARα in db/db mice. Overexpression of PPARα upregulated the expression of PPARα-targeting downstream FAO pathway-related proteins, restored renal function, and inhibited renal fibrosis in vitro and in vivo. Moreover, molecular docking and dynamics simulation analyses indicated the nephroprotective effect of DQ via binding to PPARα. Knockdown of PPARα reversed the effect of DQ on the FAO pathway and impaired the protective effect of DQ during DKD. CONCLUSION: For the first time, DQ was found to exert a renal protective effect by binding to PPARα and attenuating renal damage through the promotion of FAO in DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesQuercetinPPAR alphaDasatinibMolecular Docking SimulationAnimalsMiceMaleKidneyMice, Inbred C57BLDiabetes Mellitus, Experimental

Stichwörter der Autor:innen

Dasatinib and quercetinDiabetic kidney diseaseFatty acid oxidationPPARαTubular epithelial cells

Substanzen

QuercetinPPAR alphaDasatinib

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524003, PR China; Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang…
  • Department of Nephrology, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, PR China.
  • Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, PR China.
  • Department of Laboratory Medicine, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524003, PR China.
  • Department of Urology, The First Hospital of China Medical University, Shenyang, 110001, PR China.
  • Department of Nephrology, The First Hospital of China Medical University, Shenyang, 110001, PR China. Electronic address: 20072134@cmu.edu.cn.

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Guo, X., Wen, S., Wang, J., Zeng, X., Yu, H., Chen, Y., Zhu, X., & Xu, L. (2024). Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease. Phytomedicine, 130, 155705. https://doi.org/10.1016/j.phymed.2024.155705

Vancouver

Guo X, Wen S, Wang J, Zeng X, Yu H, Chen Y, et al. Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease. Phytomedicine. 2024;130:155705. doi:10.1016/j.phymed.2024.155705

BibTeX
@article{Guo2024,
  author = {Guo, Xiuli and Wen, Si and Wang, Jiao and Zeng, Xiaobian and Yu, Hongyuan and Chen, Ying and Zhu, Xinwang and Xu, Li},
  title = {Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease},
  journal = {Phytomedicine},
  year = {2024},
  volume = {130},
  pages = {155705},
  doi = {10.1016/j.phymed.2024.155705}
}
Kostenlos starten →